ABSTRACT: BACKGROUND: Tumor necrosis factor-? (TNF-?) may play an important role in the recalcitrant inflammatory and hyperproliferative dermatosis of psoriasis, and there may be a relationship between TNF-? polymorphisms and psoriasis risk. METHODS: We performed a meta-analysis to evaluate the associations between TNF-? polymorphisms and psoriasis. Electronic searches of Pubmed, Embase, and Web of Science were performed for all publications on the associations between TNF-? polymorphisms and psoriasis through September 26, 2012. The pooled odds ratios (ORs) with their 95% confidence interval (95%CIs) were calculated to assess the associations. RESULTS: Sixteen case-control studies with a total of 2,253 psoriasis cases and 1,947 controls on TNF-? 308 G/A polymorphism and fourteen studies on TNF-? 238 G/A polymorphism with 2,104 cases and 1,838 controls were finally included into the meta-analysis. Overall, TNF-? 308 G/A polymorphism was significantly associated with decreased risk of psoriasis under three genetic comparison models (for A versus G: fixed-effects OR 0.71, 95%CI 0.62-0.82, P < 0.001; for AG versus GG: fixed-effects OR 0.67, 95%CI 0.57-0.78, P < 0.001; for AA/AG versus GG: fixed-effects OR 0.67, 95%CI 0.58-0.78, P < 0.001). In addition, TNF-? 238 G/A polymorphism was associated with increased risk of psoriasis under three genetic models (for A versus G: fixed-effects OR 2.46, 95%CI 2.04-2.96, P < 0.001; for AG versus GG: fixed-effects OR 2.69, 95%CI 2.20-3.28, P < 0.001; for AA/AG versus GG: fixed-effects OR 2.68, 95%CI 2.20-3.26, P < 0.001). Subgroup analysis by ethnicity identified a significant association between TNF-? 308 G/A polymorphism and decreased risk of psoriasis in both Caucasians and Asians and a significant association between TNF-? 238 G/A polymorphism and increased risk of psoriasis in Caucasians. CONCLUSIONS: The meta-analysis suggests that TNF-? 308 G/A polymorphism is associated with decreased risk of psoriasis, while TNF-? 238 G/A is associated with increased risk of psoriasis.
